Reversing effect of sorcin in the drug resistance of human nasopharyngeal carcinoma

Anatomical Record

Volumn 297, Issue 2, 2014, Pages 215-221

  Liu, Xuebing ^a   Chen, Lei ^a   Feng, Bin ^b   Liu, Gang ^c  

^a SECOND HOSPITAL OF TIANJIN MEDICAL UNIVERSITY   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

^c TIANJIN HUANHU HOSPITAL   (China)

Author keywords

Multidrug resistance; Nasopharyngeal carcinoma; Sorcin

Indexed keywords

CISPLATIN; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; GLUTATHIONE; GLUTATHIONE TRANSFERASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN BCL 2; PROTEIN KINASE B; RHO FACTOR; RHODAMINE 123; RHOE PROTEIN; SMALL INTERFERING RNA; SORCIN; SURVIVIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFECT; GENE SILENCING; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; UPREGULATION;

APSEUDES;

MULTIDRUG RESISTANCE; NASOPHARYNGEAL CARCINOMA; SORCIN;

ANTINEOPLASTIC AGENTS; CALCIUM-BINDING PROTEINS; CELL LINE, TUMOR; CISPLATIN; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NASOPHARYNGEAL NEOPLASMS; NF-KAPPA B; NOSE NEOPLASMS; P-GLYCOPROTEIN; PHARYNGEAL NEOPLASMS; PTEN PHOSPHOHYDROLASE; RNA, SMALL INTERFERING;

EID: 84892671543     PISSN: 19328486     EISSN: 19328494     Source Type: Journal    
DOI: 10.1002/ar.22832     Document Type: Article

References (11)

1. Carnero A, Blanco-Aparicio C, Renner O, Link W, Leal JF. 2008. The PTEN/PI3K/AKT signaling pathway in cancer, therapeutic implications. Curr Cancer Drug Targets 8:187-198.
2. Chan SL, Ma BB. 2012. Novel systemic therapeutic for nasopharyngeal carcinoma. 2012. Expert Opin Ther Targets 16 Suppl 1:S63-S68.
3. Deng L, Su T, Leng A, Zhang X, Xu M, Yan L, Gu H, Zhang G. 2010. Upregulation of soluble resistance-related calcium-binding protein (sorcin) in gastric cancer. Med Oncol 27:1102-1108.
4. He Q, Zhang G, Hou D, Leng A, Xu M, Peng J, Liu T. 2011. Overexpression of sorcin results in multidrug resistance in gastric cancer cells with up-regulation of P-gp. Oncol Rep 25: 237-243.
5. Keppler D. 2011. Multidrug resistance proteins (MRPs, ABCCs): importance for pathophysiology and drug therapy. Handb Exp Pharmacol 201:299-323.
6. Li K, Lu Y, Liang J, Luo G, Ren G, Wang X, Fan D. 2009. RhoE enhances multidrug resistance of gastric cancer cells by suppressing Bax. Biochem Biophys Res Commun 379:212-216.
7. Razak AR, Siu LL, Liu FF, Ito E, O'Sullivan B, Chan K. 2010. Nasopharyngeal carcinoma: the next challenges. Eur J Cancer 46:1967-1978.
8. Tang K, Lin Y, Li LM. 2013. The role of phenethyl isothiocyanate on bladder cancer ADM resistance reversal and its molecular mechanism. Anat Rec (Hoboken) 296:899-906.
9. Yang YX, Chen ZC, Zhang GY, Yi H, Xiao ZQ. 2008. A subcelluar proteomic investigation into vincristine-resistant gastric cancer cell line. J Cell Biochem 104:1010-1021.
10. Zhao H, Yang J, Fan T, Li S, Ren X. 2012. RhoE functions as a tumor suppressor in esophageal squamous cell carcinoma and modulates the PTEN/PI3K/Akt signaling pathway. Tumour Biol 33:1363-1374.
11. Zheng BB, Zhang P, Jia WW, Yu LG, Guo XL. 2012. Sorcin, a potential therapeutic target for reversing multidrug resistance in cancer. J Physiol Biochem 68:281-287.